6 employees
Sticta Biologicals provides at-site production of yeast-derived recombinant proteins and key nutrients for the cell-based meat industry.
2021
$137K
from 1 investors over 1 rounds
Sticta Biologicals raised $137K on April 12, 2023
Investors: ProVeg Incubator